Skip Navigation


Carcinogenesis Advance Access originally published online on February 2, 2007
Carcinogenesis 2007 28(6):1163-1170; doi:10.1093/carcin/bgm025
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
28/6/1163    most recent
bgm025v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Li, J.
Right arrow Articles by Pang, Q.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, J.
Right arrow Articles by Pang, Q.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Nucleophosmin suppresses oncogene-induced apoptosis and senescence and enhances oncogenic cooperation in cells with genomic instability

June Li1, Daniel P. Sejas1, Sandeep Burma2, David J. Chen2 and Qishen Pang1,3,*

1 Division of Experimental Hematology, Cincinnati Children’s Research Foundation, Cincinnati Children’s Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229, USA
2 Division of Molecular Radiation Biology, Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
3 Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA

* To whom correspondence should be addressed. Tel: +1 513 636 1152; Fax: +1 513 636 3768; Email: qishen.pang{at}cchmc.org

Cells from patients with genomic instability syndromes have high predisposition to cancer. However, little is known about whether these mutant cells have high susceptibility to oncogenic transformation. We have tested the hypothesis that a defect in maintaining genome integrity is necessary but not sufficient alone for oncogenic transformation and needs to collaborate with other signals in order to produce full oncogenic transformation. Using genetically matched primary cells deficient for the Fanconi complementation group C gene (Fancc) and the ataxia telangiectasia mutated gene (Atm), we found that certain forms of oncogenic activation and cooperation require a combination of genomic instability with increased expression of nucleophosmin (NPM) to prevent oncogenic stress-induced apoptosis or senescence. Intriguingly, co-expression of c-Myc and NPM leads to a synergistic increase in the proliferation rate in Fancc–/– or Atm–/– cells. Analysis of p53 stabilization and activation by c-Myc demonstrates that over-expression of NPM significantly reduces the accumulation of the activated p53 but not the stability of p53. Moreover, NPM is shown to enhance transforming activity of co-expressed Myc and Ras in wild-type and, to a greater degree, in Fancc–/– or Atm–/– cells, suggesting a role in oncogenic cooperation. Finally, a partial knockdown of NPM is sufficient to cause massive apoptosis in Fancc–/– or Atm–/– cells co-expressing c-Myc and Ras while sparing untransformed cells. Our study demonstrates a novel mechanism of NPM tumorigenesis by establishing NPM as a crucial inhibitor of oncogene-induced apoptosis and senescence.

Abbreviations: ATM, ataxia telangiectasia mutated gene; BrdU, bromodeoxyuridine; FA, Fanconi anemia; Fancc, Fanconi complementation group C gene; MEF, mouse embryo fibroblast; NPM, nucleophosmin; SA-ß-gal, senescence-associated-ß-galactosidase; siRNA, small interfering RNA; WT, wild type

Received October 25, 2006; revised January 23, 2007; accepted January 24, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. Radziszewska, S. A. Schroer, D. Choi, P. Tajmir, N. Radulovich, J. C. Ho, L. Wang, N. Liadis, R. Hakem, M.-S. Tsao, et al.
Absence of Caspase-3 Protects Pancreatic {beta}-Cells from c-Myc-induced Apoptosis without Leading to Tumor Formation
J. Biol. Chem., April 17, 2009; 284(16): 10947 - 10956.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Z. Li, D. Boone, and S. R. Hann
Nucleophosmin interacts directly with c-Myc and controls c-Myc-induced hyperproliferation and transformation
PNAS, December 2, 2008; 105(48): 18794 - 18799.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
A. Csiszar, M. Wang, E. G. Lakatta, and Z. Ungvari
Inflammation and endothelial dysfunction during aging: role of NF-{kappa}B
J Appl Physiol, October 1, 2008; 105(4): 1333 - 1341.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Zhou, W. Du, T. Koretsky, G. C. Bagby, and Q. Pang
TAT-mediated intracellular delivery of NPM-derived peptide induces apoptosis in leukemic cells and suppresses leukemogenesis in mice
Blood, September 15, 2008; 112(6): 2474 - 2483.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.